American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The TQCC of American Journal of Clinical Oncology-Cancer Clinical Trials is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?53
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer32
Cardiac Angiosarcomas28
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia28
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy24
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma17
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients15
Death From Infection Among Patients Living With Cancer13
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy13
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers13
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer12
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer11
Third-line Treatment for Metastatic Triple-negative Breast Cancer11
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer10
Efficacy and Prognostic Factors of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-small Cell Lung Cancer10
Lack of Impact of Expansion Size From Gross Tumor Volume to Planning Target Volume on Control Rates and Patterns of Recurrence in Fractionated Radiotherapy for WHO Grade 1 Meningiomas9
Hypofractionated Radiation Therapy9
Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma9
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus8
Durable Responses in Patients With Advanced Cholangiocarcinoma on Sequential Dual-agent Immunotherapy After Progressing on Single-agent Immunotherapy8
Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer8
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer8
Prospective Validation of An Inpatient Metastatic Spine Neoplasm Score To Assess the Optimal Radiation Therapy Intervention Modality8
Beyond the Clinic8
Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non−Small Cell Lung Cancer8
The Effect of Biomarkers on Clinical Trial Risk in Gastric Cancer7
Outcome Predictors of Hardware Complications in Head and Neck Free Flap Reconstruction7
Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites7
Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas7
Temporality and Patterns of Metastatic Recurrence in Node-Positive Breast Cancer Following Trimodality Therapy7
Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases7
ACR–ARS Practice Parameter for Radiation Oncology7
SBRT vs. Y907
Care Delivery in Cancer Patients With Asymptomatic COVID-19 Infection in a Tertiary, Safety-Net Hospital in Houston, Texas7
Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 20157
A Meta-analysis on Effects of Chimeric Antigen Receptor T-cell Therapy in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia7
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy7
Can Cancer Patients With Autoimmune Diseases Use Immunotherapy?6
A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma6
The Role of the Quality of Relationship in Couples Facing Treatment for Breast Cancer6
Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas6
Crossover in Adjuvant Trastuzumab Trials6
Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy6
Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies6
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy6
Accuracy of Medical Oncology Prognosis for Metastatic Cancer Patients Evaluated for Enrollment Onto an Ongoing Randomized Clinical Trial6
Early Cancer Screening Impressions of African-American Breast Cancer Patients Enrolled on the Navigator-Assisted Hypofractionation (NAVAH) Trial6
Disparities in Receipt of Adjuvant Immunotherapy among Stage III Melanoma Patients6
Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer5
Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer5
Treatment of Cancer Pain5
Therapeutic Evaluation of Induction Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma With Low-risk N Stage5
Intramedullary Nailing Versus Compound Plate Osteosynthesis in Pathologic Diaphyseal Humerus Fractures5
Why Basic Science Education Matters in Radiation Oncology5
Surveillance Following Hepatic Resection for Colorectal Liver Metastases in Elderly Patients5
Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy5
Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer5
Utilization and Survival Impact of Hypofractionated Radiotherapy in Stage I Non-small Cell Lung Cancer5
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer5
Mortality Patterns of Esophageal Cancer in the United States4
Impact of Time From Diagnosis to Treatment Start on the Outcomes of Patients With Nonmetastatic Anal Squamous Cell Carcinoma4
Laparoscopic Versus Abdominal Radical Hysterectomy4
Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer4
Preoperative Computed Tomography Radiomics Analysis for Predicting Receptors Status and Ki-67 Levels in Breast Cancer4
Sacituzumab Govitecan-hziy in Breast Cancer4
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors4
Brachial Plexus Constraints in Two-Fraction Spine Stereotactic Body Radiation Therapy4
Navigator-Assisted Hypofractionation (NAVAH) Phase I Clinical Trial of Breast Cancer Patients4
Stereotactic Body Radiotherapy for Prostate Cancer4
Association Between Statin Exposure and Incidence and Prognosis of Prostate Cancer4
The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status4
Early Experience With Biologically Effective Dose-Comparable Short-Course Whole Brain Radiation Therapy for Metastatic Intracranial Disease4
Long-Term Outcomes after Abdominal Radiation for Wilms Tumor4
The microRNA-34 Family and Its Functional Role in Lung Cancer4
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non–Small Cell Lung Cancer4
Clinical Characteristics and Survival Analysis of Patients With Second Primary Malignancies After Hepatocellular Carcinoma Liver Transplantation3
A Simple, Novel Prognostic Score in Platinum Sensitive Relapsed Ovarian Cancer3
Five Fraction External Beam Partial Breast Irradiation3
Geospatial Mapping of Head and Neck Cancer Research3
Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous Ovarian Cancer Based on Competing Risk Model3
Long COVID in Cancer3
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors3
Social Determinants of Health in Oncology3
Efficacy and Safety of Probiotics as Adjunctive Therapy in Cancer Treatment3
A Systematic Review of Conversion to Resectability in Unresectable Metastatic Colorectal Cancer Chemotherapy Trials3
Racial and Gender Differences in Patient Satisfaction Scores Among Oncologists3
A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer3
The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies3
A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers3
Prognostic Value of the Cutoffs for HALP in Endometrial Cancer3
Metaplastic Breast Carcinoma3
Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients3
Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials3
Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer3
Efficacy and Safety of BRCA-targeted Therapy (Polyadenosine Diphosphate-ribose Polymerase Inhibitors) in Treatment of BRCA-mutated Breast Cancer3
Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer3
A Novel Nomogram for Predicting Breast Cancer–specific Survival in Male Patients3
Does Current Training in Radiation Oncology Prepare Radiation Oncologists to Optimally Manage Patients With Head and Neck Cancer?3
The Concerning Disaggregation of Gender and Racial/Ethnicity Disparity Investigation at Recent ASCO Annual Meetings3
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma3
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases3
Practice Patterns of Surveillance in Sentinel Lymph Node-Positive Malignant Melanoma​​​3
0.058923006057739